Physician profile
Jennifer Wright
NPI 1568943942
$2,179.04
in general payments reported to CMS, 2019-2025
14 companies · $1,764 in 2025
The $1,764 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $55.80 · 2024: $359 · 2025: $1,764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,174 · Education: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,174.04 |
| Education | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $329.30 | 2024-2025 | |
| Janssen Biotech, INC. | $242.31 | 2024-2025 | Tremfya, Stelara, Simponi |
| Incyte Corporation | $240.53 | 2025 | Opzelura |
| Genzyme Corporation | $238.00 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $231.41 | 2024-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $193.79 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Galderma Laboratories, L.P. | $180.84 | 2025 | Nemluvio, Aklief |
| Novartis Pharmaceuticals Corporation | $138.37 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $128.35 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $91.65 | 2023-2025 | Camzyos, Sotyktu |
| Organon LLC | $70.60 | 2025 | |
| Leo Pharma INC. | $56.09 | 2025 | Anzupgo |
| Ucb, INC. | $19.80 | 2025 | Bimzelx |
| Pfizer INC. | $18.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.